Pediatric cardiac transplantation: Management issues

Journal of Pediatric Nursing

Volumn 16, Issue 5, 2001, Pages 320-331

  Luikart, Helen ^a,b  

^a STANFORD UNIVERSITY   (United States)

^b Falk Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOPSY; CLASSIFICATION; FORECASTING; GRAFT REJECTION; HEART TRANSPLANTATION; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION CONTROL; METHODOLOGY; MORBIDITY; MORTALITY; NURSING; PATIENT SELECTION; PEDIATRIC NURSING; PERIOPERATIVE PERIOD; REVIEW; STATISTICS; SURVIVAL;

BIOPSY; FORECASTING; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSION; INFECTION CONTROL; MORBIDITY; PATIENT SELECTION; PEDIATRIC NURSING; PERIOPERATIVE CARE; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 0035486949     PISSN: 08825963     EISSN: None     Source Type: Journal    
DOI: 10.1053/jpdn.2001.26569     Document Type: Article

References (42)

1. Bailey, L., Nehlsen-Cannarella, S., Concepcion, W., & Jolley, W. (1985). Baboon-to-human cardiac xenotransplantation in a neonate. Journal of the American Medical Association, 254, 3321-3329.
2. Baum, D., Bernstein, D., Starnes, V., Oyer, P., Pitlick, P., Stinson, E., & Shumway, N. (1991). Pediatric heart transplantation at Stanford: Results of a 15-year experience. Pediatrics, 88(2), 203-214.
3. Bernstein, D., Baum, D., Berry, G., Dahl, G., Weiss, L., Starnes, V., Bamberg, P., & Stinson, E. (1993). Neoplastic disorders after pediatric heart transplantation. Circulation, 88(5), II230-II237.
4. Billingham, M., Carry, C., Hammond, M., Kemnitz, J., Marboe, C., & Mcallister, H. (1990). A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart rejection study groups. Journal of Heart and Lung Transplantation, 9, 587-592.
5. Boucek, M., Faro, A., Novick, R., Bennett, L., Fiol, B., Keck, B., & Hosenpud, J. (1999). The registry of the International Society of Heart and Lung Transplantation: Third official pediatric report - 1999. Journal of Heart and Lung Transplantation, 18(12), 1151-1165.
6. Boucek, R., Naftel, D., Boucek, M., Chinnock, R., Morrow, R., Pahl, E., & Disano, S. (1999). Induction immuno-therapy in pediatric heart transplant recipients: A multi-center study. Journal of Heart and Lung Transplantation, 18(5), 460-469.
7. Braulin, E., Shumaway, S., Bolman, R., McDonald, K., Ringg, W., Olivari, M., & Nakheh, R. (1998). Heart transplantation in the pediatric age group and for end-stage congenital heart defects. Mayo Clinic Proceedings, 73(10), 1025-1026.
8. Chin, C., Akhtar, M., Rosenthal, D., & Bernstein, D. (2000). Safety and utility of the routine surveillance biopsy in pediatric patients 2 years after heart transplantation. Journal of Pediatrics, 136, 238-242.
9. Cooley, D. (1991). Session I: Pediatric heart transplantation in historical perspective. Journal of Heart and Lung Transplantation, 10, 787-790.
10. Edwards, N., Rajasinghe, H., John, R., Chen, J., Itescu, S., & Mancicni, D. (1999). Cardiac transplantation in over 1000 patients: A single institution experience from Columbia University. Clinical Transplants, 249-259.
11. Gao, S., Alderman, E., Schroeder, J., Silverman, J., & Hunt, S. (1988). Accelerated coronary vascular disease in the heart transplant patient: Coronary arteriographic findings. Journal of American College of Cardiology, 12, 234-340.
12. Herzberg, G., Rossi, A., Courtney, M., Lansman, S., Gelb, B., Parness, I., & Wyman, W. (1998). Usefulness of tacrolimus versus cyclosporine after pediatric heart transplantation. American Journal of Cardiology, 82(4), 541-543.
13. Hunt, S., Schroeder, J., Berry, G., & Billingham, B. (1997). Cardiac transplantation, mechanical ventricular support, and endomyocardial biopsy. In R. Alexander, R. Schlant, V. Fuster, R. O'Rouke, R. Roberts, & E. Sonnenblick (Eds.), Hurst's The Heart (9th ed.) 799-821. New York: McGraw-Hill.
14. Katz, I., & Epstein, S. (1992). Post transplantation bone disease. Journal of Bone and Mineral Research, 7(2), 123-126.
15. Kobashigawa, J., Katznelson, S., Laks, H., Johnson, J., Yeatman, L., & Wang, X. (1995). Effect of Pravastatin on outcomes after cardiac transplantation. New England Journal of Medicine, 333, 621-627.
16. Kobashigawa, J. (1990). Low-dose Lovastatin safely lowers cholesterol after cardiac transplantation. Circulation, 82(5), IV281-IV284.
17. Leduc, D., & Luikart, H. (2000). Cardiac surgery. In S. Woods, E. Froelicher, & S. Motzer (Eds.), Cardiac Nursing, (pp. 580-613). Philadelphia: Lippincott.
18. Leonard, H., O'Sullivan, J., & Dark, J. (2000). Long-term follow-up of pediatric cardiac transplant recipients on a steroid free regimen: The role of endomyocardial biopsy. Journal of Heart and Lung Transplantation, 19(5), 409-472.
19. Lyons, M. (1993). Immunosuppressive therapy after cardiac transplantation: Teaching pediatric patients and their families. Critical Care Nurse, 12, 39-45.
20. Marx, M., Salzer-Muhar, U., & Wimmer, M. (1999). Extra-corporeal life support in pediatric patients with heart failure. Artificial Organs, 23(11), 1001-1005.
21. Mehta, U., Laks, H., Sadeghi, A., Marelli, D., Odim, J., Alejos, J., Kim, M., Atkinson, J., & Kim, C. (2000). Extra corporeal membrane oxygenation for cardiac support in pediatric patients. The American Surgeon, 66, 879-886.
22. Merigan, T., Renlund, D., & Keay, S. (1992). A controlled trial of Ganciclovir to prevent cytomegalovirus disease after heart transplantation. New England Journal of Medicine, 326, 1182-1192.
23. Micromedex Healthcare Series: Micromedex, Inc. Greenwood Village, CO. (Edition expires 9/2001) [On-line]. Available: http://hcs.mdx.com (Accessed on January 22, 2001).
24. Moran, A., Lipshultz, S., Rifai, N., O'Brien, P., Moonry, H., Perry, S., Perez-Atayde, A., Lipsitz, S., & Colan, S. (2000). Non-invasive assessment of rejection in pediatric transplant patients: Serologic and echocardiographic prediction of biopsy proven myocardial rejection. Journal of Heart and Lung Transplantation, 19(8), 756-764.
25. Pahl, E., Crawford, S., Cohn, R., Rodgers, R., Wax, D., & Backer, C. (2000). Reversal of sevier late left ventricular failure after pediatric heart transplantation and possible role of plasmapheresis. American Journal of Cardiology, 85(6), 735-739.
26. Pahl, E., Crawford, S., Swenson, J., Duffy, C., Fricker, F., Backer, C., Mavroudis, C., & Chaudhy, F. (1999). Dobutamine stress echocardiography: Experience in pediatric heart transplant recipients. Journal of Heart and Lung Transplantation, 18(7), 725-732.
27. Patel, R., Snydman, D., Rubin, R., Ho, M., Pescovitz, M., Martin, M., & Paya, C. (1996). Cytomegalovirus prophylaxis in solid organ transplant recipients. Transplantation, 61(9), 1279-1289.
28. Peter, G. (Ed). (1997). Red Book: Report of the committee on Infectious Diseases (24th ed.). Elk Grove Village, IL: American Academy of Pediatrics.
29. Putzer, G., Cooper, D., Keehn, C., Asnate-Korang, A., Boucek, M., & Boucek, R. (2000). An improved echocardiographic rejection-surveillance strategy following pediatric heart transplantation. Journal of Heart and Lung Transplantation, 19(12), 1166-1174.
30. Razzouk, A., Chinnock, R., Dearani, J., Gundry, S., Bailey, S., & Leonard, L. (1998). Cardiac retransplantation for graft vasculopathy in children: Should we continue to do It? Archives of Surgery, 133(8), 881-885.
31. Schroeder, J., Gao, S., Alderman, E., Hunt, S., Johnstone, I., Boothroyd, D., Wiederhold, V., & Stinson, E. (1993). A preliminary study of diltazem in the prevention of coronary artery disease in heart-transplant recipients. New England Journal of Medicine, 328(3), 164-170.
32. Shaddy, R., Nafftel, D., Kirklin, J., Boyle, G., Mcgiffin, D., Towbin, J., Ring, S., Pearce, B., Addonizio, L., & Morrow, R. (1996). Outcome of cardiac transplantation on children: Survival in a contemporary multi-institutional experience. Circulation, 94(9), II69-II72.
33. Shaddy, R., Revenaugh, J., Orsmond, G., & Lloyd, Y. (2000). Coronary interventional procedures in pediatric heart transplant recipients with allograft vasculopathy. American Journal of Cardiology, 85(11), 1370-1372.
34. Shumway, S. (1998). Heart transplantation in the pediatric age group and for end-stage congenital heart defects. Mayo Clinic Proceedings, 73(10), 1025-1026.
35. Stark, R., McGinn, A., & Wilson, R. (1991). Chest pain in cardiac-transplant recipients - evidence of sensory reinnervation after cardiac transplantation. New England Journal of Medicine, 324, 1791-1794.
36. Swenson, J., Fricker, F., & Armitage, J. (1995). Immunosuppression switch in pediatric heart transplant recipients: Cyclosporine to FK 506. Journal of American College of Cardiology, 25(5), 1183-1188.
37. Tejani, A., Cortes, L., & Sullivan, E. (1996). A longitudinal study of the natural history of growth post-transplantation. Kidney International-Supplement, 49(53), S103-S108.
38. Thelan, L., Urden, L., Lough, M., & Stacy, K. (Eds) (1998). Transplantation. In Critical Care Nursing, Diagnosis, and Management. (3rd ed., pp 1171-1220), St. Louis, MO: Mosby.
39. Tilney, N. (1999). Chronic rejection and its risk factors. Transplantation Proceedings, 31, 41S-44S.
40. Tsai, E., Shemie, S., Hebert, D., McCarthy, L., Furst, S., & Cox, P. (1999). Potential organ loss in pediatric organ donation. Transplantation, 67(7), S91-S92.
41. United National Organ Sharing (UNOS). 1999 Annual Report of the U.S. Scientific Registry for the Transplant Recipients and the Program Procurement and Transplantation Network: Transplant Data: 1989-1998. Rockville, MD: U.S. Department Of Health and Human Services Administration, Office of Special Programs, Division of Transplantation; Richmond, VA: UNOS.
42. Zangwill, S., Daphne, H., Kichuk, M., Garvin, J., Stolar, C., Haddad, J., Stylianos, S., Michler, R., Chaddburn, A., Knowles, D., & Addonizzio, L. (1998). Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients. Journal of Heart and Lung Transplantation, 17(12), 1161-1166.